Baillie Gifford & Co’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $34.3M | Sell |
|
|||||
2023
Q3 | $32.7M | Sell |
|
|||||
2023
Q2 | $45M | Sell |
|
|||||
2023
Q1 | $125M | Buy |
|
|||||
2022
Q4 | $112M | Sell |
|
|||||
2022
Q3 | $133M | Sell |
|
|||||
2022
Q2 | $257M | Sell |
|
|||||
2022
Q1 | $774M | Sell |
|
|||||
2021
Q4 | $999M | Buy |
|
|||||
2021
Q3 | $1.12B | Buy |
|
|||||
2021
Q2 | $1.4B | Buy |
|
|||||
2021
Q1 | $1.44B | Buy |
|
|||||
2020
Q4 | $1.45B | Buy |
|
|||||
2020
Q3 | $1.37B | Buy |
|
|||||
2020
Q2 | $1.14B | Buy |
|
|||||
2020
Q1 | $895M | Buy |
|
|||||
2019
Q4 | $480M | Buy |
|
|||||
2019
Q3 | $254M | Buy |
|
|||||
2019
Q2 | $58.7M | Sell |
|
|||||
2019
Q1 | $49.3M | Buy |
|
|||||
2018
Q4 | $36.7M | Buy |
|
|||||
2018
Q3 | $60.4M | Buy |
|
|||||
2018
Q2 | $35.6M | Buy |
|
|||||
2018
Q1 | $21.4M | Buy |
|
|||||
2017
Q4 | $12.1M | Buy |
|
|||||
2017
Q3 | $10.1M | Buy |
|
|||||
2017
Q2 | $9.89M | Buy |
|
|||||
2017
Q1 | $5.08M | Buy |
|